Biological Age Calculator Guide: Calculate Levine PhenoAge From Blood Biomarkers
“Biological age” is not one universally standardized medical measurement. Researchers have developed many methods intended to summarize different aspects of aging, including blood-chemistry models, physical-function measures, frailty indexes, physiological composites, and DNA methylation clocks.
This calculator uses one specific published model: Levine Phenotypic Age, commonly called PhenoAge. It does not use a lifestyle questionnaire and it does not analyze DNA methylation.
PhenoAge was developed from U.S. National Health and Nutrition Examination Survey data using mortality modeling. Researchers began with a larger collection of clinical biomarkers and used statistical selection methods to identify a final set of nine blood biomarkers plus chronological age.
Those nine biomarkers are albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean corpuscular volume, red-cell distribution width, alkaline phosphatase, and white blood cell count.
The model combines those variables into a mortality-related linear predictor. That predictor is transformed through a Gompertz mortality model and finally expressed on an age-like scale.
This age scale is what makes the result intuitive. In the underlying research framework, PhenoAge represents approximately the chronological age in a reference population associated with a similar modeled mortality risk.
A 50-year-old whose PhenoAge is 44 therefore receives an age-like model result six years below chronological age. It does not mean six years have literally been removed from the person’s cells, lifespan, or calendar age.
Likewise, a PhenoAge above chronological age should not be interpreted as proof that the body has biologically aged by an exact additional number of years. It indicates that the entered biomarker profile maps to an older age-like mortality-risk value under this particular statistical model.
The original validation study applied PhenoAge to more than 11,000 U.S. adults from NHANES and found that the measure was associated with all-cause mortality, disease burden, and several aging-related outcomes even after chronological age was considered.
The model is therefore scientifically more substantial than an arbitrary “health habits = age points” quiz. At the same time, association at the population level does not convert an individual calculator result into a diagnosis or personalized prediction of lifespan.
There is also no universally accepted gold-standard biological-age measurement. Different aging algorithms can use different inputs, statistical targets, tissues, and definitions of aging and can therefore return different age estimates for the same person.
Recent scientific discussion has become increasingly cautious about translating biological-age clocks into individual clinical decisions. A 2025 review of epigenetic clocks, for example, argued that technical variability, tissue effects, biological noise, model construction, and lack of validated individual thresholds limit their current personal clinical usefulness.
PhenoAge is not itself an epigenetic clock, but the broader lesson still applies: an age-like biomarker output should not be given more precision or clinical authority than the model has been validated to support.
This calculator therefore reproduces the published Levine PhenoAge model transparently, converts common U.S. laboratory units where necessary, shows the difference from chronological age, and places interpretation limits directly beside the result.
How to Calculate Phenotypic Age From Chronological Age and Nine Laboratory Tests
- Use laboratory results from the same testing period: Enter biomarkers from the same blood draw or clinically comparable time period rather than mixing values collected months or years apart.
- Enter chronological age: Use current chronological age in years at approximately the time the laboratory measurements were obtained.
- Enter albumin: The calculator accepts the displayed laboratory unit and converts it to the unit required by the PhenoAge equation.
- Enter creatinine and glucose carefully: U.S. laboratories commonly report these biomarkers in mg/dL while the published equation uses SI units, so unit conversion must occur before calculation.
- Enter CRP as a positive value: The equation uses the natural logarithm of CRP. Zero cannot be entered directly because ln(0) is mathematically undefined.
- Enter CBC-derived biomarkers: Use lymphocyte percentage, mean corpuscular volume, red-cell distribution width, and white blood cell count from the laboratory report.
- Enter alkaline phosphatase: Use the laboratory value in units per liter.
- Review the PhenoAge result: Interpret the number as an age-like mortality-model output rather than a literal measurement of tissue age.
- Compare with chronological age cautiously: A positive or negative difference is descriptive of the model result. It is not years of lifespan lost or gained.
- Interpret abnormal laboratory values clinically: Discuss abnormal biomarkers according to their actual medical meaning rather than trying to manipulate individual values solely to improve the PhenoAge score.
Formula and variables
Levine PhenoAge is not a simple weighted average of ages. The nine biomarkers and chronological age first generate a linear mortality predictor. That predictor is transformed into modeled mortality risk using the published Gompertz survival model and then converted into an age-like value corresponding to comparable mortality risk in the reference population.
xb = −19.90667 − 0.03359(Albumin g/L) + 0.00951(Creatinine μmol/L) + 0.19532(Glucose mmol/L) + 0.09537 ln(CRP mg/L) − 0.012(Lymphocyte %) + 0.02676(MCV fL) + 0.33062(RDW %) + 0.00187(ALP U/L) + 0.05542(WBC 10³/μL) + 0.08035(Age); xb is transformed through the published Gompertz mortality model and then converted to the PhenoAge scale- Age — Chronological age
- Current age in years and one of the ten variables in the published PhenoAge equation.
- Alb — Albumin
- Serum albumin, entered in g/dL and converted to g/L when necessary.
- Cr — Creatinine
- Serum creatinine, entered in mg/dL and converted to μmol/L for the published equation.
- Glu — Glucose
- Blood glucose, entered in mg/dL and converted to mmol/L for the equation.
- CRP — C-reactive protein
- C-reactive protein in mg/L. The natural logarithm of CRP is used, so the mathematical input must be greater than zero.
- Lymph — Lymphocyte percentage
- Percentage of white blood cells reported as lymphocytes.
- MCV — Mean corpuscular volume
- Average red-blood-cell volume measured in femtoliters.
- RDW — Red-cell distribution width
- Variation in red-blood-cell size expressed as a percentage under the laboratory reporting method used by the model.
- ALP — Alkaline phosphatase
- Serum alkaline phosphatase measured in units per liter.
- WBC — White blood cell count
- White blood cell concentration expressed as approximately 10³ cells per microliter.
- xb — Linear mortality predictor
- The weighted combination of chronological age and nine biomarkers used in the published mortality model.
- PhenoAge — Phenotypic Age
- The mortality-derived model result transformed onto an age-like scale.
Scenario 1: Complete Laboratory Panel Produces a PhenoAge Below Chronological Age
A 45-year-old enters the same representative laboratory profile used by the existing calculator example. The calculator converts U.S. conventional laboratory units where necessary and applies the published Levine PhenoAge model.
- Chronological age
- 45 years
- Albumin
- 4.3 g/dL
- Creatinine
- 0.9 mg/dL
- Glucose
- 90 mg/dL
- C-reactive protein
- 1.0 mg/L
- Other biomarkers
- Example lymphocyte %, MCV, RDW, alkaline phosphatase, and WBC values shown in the calculator
- Convert albumin from 4.3 g/dL to 43 g/L.
- Convert creatinine from 0.9 mg/dL to approximately 79.6 μmol/L.
- Convert glucose from 90 mg/dL to approximately 5.0 mmol/L.
- Calculate the natural logarithm of CRP.
- Insert age and all nine biomarkers into the published linear predictor.
- Transform the linear predictor through the published mortality-risk equation.
- Convert the resulting modeled risk to the PhenoAge scale.
Result: Using the complete example panel, the calculator returns a Levine PhenoAge of approximately 40.5 years.
The result is approximately 4.5 years below the chronological age of 45. This means the entered biomarker profile maps to a younger age-like mortality-risk value in the model. It does not mean 4.5 years were removed from the person’s lifespan or that biological aging has literally reversed.
Understanding your results
Levine PhenoAge estimate
This is the age-like output from the published mortality-derived biomarker model.
It should not be described simply as the literal age of the person’s body or cells.
Difference from chronological age
Subtracting chronological age from PhenoAge provides an intuitive descriptive difference.
A negative value means the model output is younger than chronological age; a positive value means it is older.
Younger PhenoAge result
A younger result corresponds to a biomarker profile associated with a younger mortality-risk age under this model.
It does not guarantee longer life or freedom from disease.
Older PhenoAge result
An older result corresponds to a biomarker profile associated with an older mortality-risk age under this model.
It is not by itself a diagnosis, prognosis, or proof of accelerated cellular aging.
Laboratory context
Individual biomarkers can change with acute illness, inflammation, medications, hydration status, laboratory method, fasting status, and other circumstances.
The PhenoAge result inherits those changes.
Assumptions
- All laboratory measurements belong to the same person.
- Laboratory values are entered accurately using the displayed units.
- Chronological age corresponds approximately to the time the laboratory tests were performed.
- U.S. conventional laboratory values are converted correctly to the units required by the published equation.
- CRP is greater than zero because the model requires its natural logarithm.
- The published NHANES-derived model is being reproduced for educational and research-oriented estimation.
- The result is interpreted as a statistical aging biomarker rather than a literal biological-age ground truth.
- The calculator does not infer diagnosis, treatment, or individual life expectancy.
Limitations
- There is no single universally accepted ground truth or gold-standard biological-age measure.
- The BioAge research toolkit notes that aging biomarkers remain a work in progress and that no gold-standard aging biomarker currently exists.
- Levine PhenoAge was developed from U.S. NHANES mortality data and reflects associations within the populations and measurements used to develop the model.
- The original model was developed using mortality associations and should not be interpreted as a direct measurement of cellular, molecular, organ, or epigenetic age.
- The calculator is not a DNA methylation or epigenetic clock.
- PhenoAge and DNA methylation PhenoAge are related concepts but are not the same measurement. The latter uses DNA methylation patterns trained to approximate aspects of the clinical PhenoAge phenotype.
- A single PhenoAge result cannot establish that aging is accelerating or slowing within one person.
- Repeated measurements can be affected by laboratory variation, acute inflammation, illness, medication changes, hydration, fasting status, and other transient factors.
- The original validation research established associations at the population level and does not establish deterministic predictions for individuals.
- A PhenoAge result younger than chronological age does not guarantee increased lifespan.
- A PhenoAge result older than chronological age does not specify how many years of life have been lost.
- The model should not be used to diagnose cardiovascular disease, cancer, diabetes, kidney disease, infection, anemia, immune dysfunction, or another condition.
- Abnormal individual biomarkers can require medical evaluation regardless of whether the combined PhenoAge result appears favorable.
- Extreme input values can produce unusual outputs because the equation applies fixed statistical coefficients to the entered values.
- Different biological-age algorithms can return substantially different results for the same person because they measure or predict different constructs.
- Recent scientific reviews have cautioned against converting aging-clock results into individual medical decisions without demonstrated clinical validity and utility.
- The calculator should not be used to justify starting, stopping, or changing medication, supplements, hormone therapy, dietary restriction, or other treatment.
Common mistakes
- Calling PhenoAge an epigenetic clock.
- Calling the result a direct measurement of cellular age.
- Treating chronological age minus PhenoAge as years added to life expectancy.
- Treating PhenoAge above chronological age as years of life lost.
- Entering albumin in g/dL when the internal equation expects g/L without conversion.
- Entering creatinine in mg/dL directly into a coefficient designed for μmol/L.
- Entering glucose in mg/dL directly into a coefficient designed for mmol/L.
- Entering zero CRP despite the logarithmic transformation.
- Using log base 10 instead of the natural logarithm for CRP.
- Mixing laboratory tests from unrelated dates.
- Entering biomarkers measured during acute illness and interpreting the result as a stable aging trait.
- Trying to lower one biomarker solely because its equation coefficient appears unfavorable.
- Comparing results generated by different biological-age models as though they were interchangeable.
- Treating a one- or two-year model difference as incontrovertible biological change.
Practical use cases
Scenario 2: Reproduce Levine PhenoAge from routine blood work
A user has all nine required laboratory biomarkers plus chronological age.
The calculator reproduces the published mortality-derived age estimate after converting units correctly.
Scenario 3: Compare phenotypic and chronological age
A 55-year-old receives a PhenoAge result of 59.
The calculator can report a +4-year age-like model difference while explicitly stating that this is not four years of life expectancy lost.
Scenario 4: Repeat testing under comparable conditions
A researcher has laboratory panels collected under standardized conditions at two time points.
The calculator can reproduce PhenoAge at both dates, while interpretation of the change still requires attention to laboratory methods, health changes, and statistical noise.
Scenario 5: Acute inflammatory illness
CRP and white blood cell count are temporarily elevated during an infection.
The resulting PhenoAge can shift because those biomarkers are explicit model inputs, so the result should not automatically be interpreted as permanent accelerated aging.
Scenario 6: Missing one biomarker
The user has eight of the nine laboratory inputs.
The published PhenoAge algorithm cannot be reproduced faithfully by simply assigning the missing biomarker a normal or zero value.
Planning and decision guide
This calculator implements Levine PhenoAge specifically
The existing calculator uses chronological age and nine routine laboratory biomarkers to reproduce the published Phenotypic Age model.
The page should therefore identify the method explicitly instead of implying that all concepts called biological age are equivalent.
Chronological age remains an input to PhenoAge
PhenoAge is not independent of calendar age.
Chronological age itself carries a positive coefficient in the published mortality model.
Scenario 7: Identical biomarkers at different chronological ages
A 35-year-old and a 65-year-old enter identical laboratory values.
Their PhenoAge outputs will not be identical because chronological age is part of the formula.
The model uses nine blood biomarkers
Albumin, creatinine, glucose, CRP, lymphocyte percentage, MCV, RDW, alkaline phosphatase, and white blood cell count are the final selected clinical markers.
The original research selected these from a larger biomarker pool using mortality prediction.
The biomarkers span multiple physiological systems
The panel contains signals related to inflammation, immune status, metabolic regulation, liver-associated chemistry, kidney function, and hematology.
The result is therefore a multisystem statistical composite rather than a test of one organ.
Albumin contributes negatively to the linear predictor
Under the published coefficient structure, higher albumin lowers the mortality linear predictor when other variables remain mathematically fixed.
This coefficient should not be converted into advice to manipulate albumin independently of its clinical context.
Creatinine is included as a kidney-related biomarker
Creatinine contributes positively to the published mortality predictor.
Its clinical interpretation depends on muscle mass, kidney function, medications, hydration, and other factors.
Scenario 8: Athlete with relatively high creatinine
Creatinine can be influenced by muscle mass and other non-aging factors.
The equation still applies its coefficient, demonstrating why PhenoAge should not replace individual biomarker interpretation.
Glucose contributes to the mortality-derived score
The original equation uses glucose expressed in mmol/L.
U.S. mg/dL values must therefore be converted before the coefficient is applied.
CRP is logarithmically transformed
C-reactive protein has a skewed distribution and enters the model as the natural logarithm of CRP.
This is why CRP must be positive mathematically.
Scenario 9: Laboratory reports CRP below detection limit
A report such as “<0.2 mg/L” is not the same as a measured value of zero.
The application should not silently replace it with zero because ln(0) is undefined.
Below-detection CRP requires explicit handling
If the interface allows censored laboratory values, the substitution rule should be documented.
Otherwise users should enter the numeric value reported by the laboratory when available rather than inventing one.
Lymphocyte percentage is different from absolute lymphocyte count
The published equation uses lymphocyte percentage.
An absolute lymphocyte count should not be substituted directly.
MCV describes average red-cell size
Mean corpuscular volume is reported in femtoliters.
The model treats it as one component of the mortality-associated biomarker profile.
RDW reflects variation in red-cell size
Red-cell distribution width enters with a relatively large positive coefficient in the original linear predictor.
That statistical coefficient does not make RDW an independent aging diagnosis.
Alkaline phosphatase is not an age measurement by itself
ALP can vary with hepatobiliary, bone, physiologic, medication, and other factors.
Its contribution to PhenoAge should not replace ordinary clinical interpretation.
White blood cell count can shift with acute conditions
Infection, inflammation, medications, stress, and other transient factors can change WBC.
A temporary WBC change can therefore change the model output.
Scenario 10: PhenoAge during infection versus recovery
The same person can produce different results several weeks apart because CRP and WBC have normalized.
That difference does not by itself prove that biological aging rapidly reversed.
The first stage is a linear predictor
The coefficients combine age and biomarkers into xb.
xb itself is not PhenoAge and should not be shown as though it were an age.
The second stage estimates mortality-related risk
The original method parameterizes a Gompertz proportional-hazards model.
The resulting risk quantity is then transformed to an equivalent age scale.
The age scale is what makes PhenoAge interpretable
Rather than returning only a mortality-risk index, the model maps that risk to an age-like number.
The age-like representation is useful but also creates the risk of consumers interpreting it too literally.
Scenario 11: PhenoAge 60 for chronological age 50
The model associates the entered profile with an older mortality-risk age.
It does not mean every tissue in the body is biologically 60 years old.
Raw PhenoAge difference is not identical to research PhenoAgeAccel
A simple consumer result often displays PhenoAge minus chronological age.
In the original research, PhenoAge Acceleration was defined using residuals from regression of PhenoAge on chronological age rather than merely subtracting one age from the other.
This distinction should be preserved
Label the consumer output “Difference from chronological age.”
Do not call it formal PhenoAgeAccel unless the calculator actually applies the population regression required by that construct.
Scenario 12: PhenoAge 47 and chronological age 50
The simple displayed difference is −3 years.
That does not automatically equal the formal research PhenoAgeAccel residual.
The original validation used NHANES IV
The major validation study analyzed more than 11,000 U.S. adults and found PhenoAge associated with mortality and disease burden across multiple subgroups.
These results support use as a population aging biomarker but do not establish a deterministic personal prognosis.
Mortality association should not become life-expectancy prediction
A biomarker can correlate with mortality risk without specifying the date or cause of an individual person’s death.
This calculator should therefore never output “years left to live.”
The model is not a diagnosis
The nine laboratory tests each have independent clinical uses.
PhenoAge mathematically combines them but does not replace diagnosis of the conditions those tests can help evaluate.
Scenario 13: Abnormal glucose but favorable PhenoAge
Other inputs can offset the glucose contribution mathematically.
A favorable combined age estimate does not make an abnormal glucose result clinically irrelevant.
Do not optimize the equation instead of health
A user can see which coefficients raise or lower the model result.
That does not mean deliberately manipulating a laboratory biomarker to lower the calculator score is medically beneficial.
Medication decisions should never be made from PhenoAge alone
Changing glucose medication, anti-inflammatory treatment, supplements, or other therapy can have consequences far beyond the composite score.
Clinical decisions should target actual medical indications.
Biological age is a family of constructs
Different methods attempt to quantify aging using different biological layers and statistical targets.
Blood chemistry, DNA methylation, proteomics, metabolomics, organ function, frailty, and physiological performance do not measure exactly the same thing.
The BioAge toolkit implements multiple methods
Published BioAge software includes PhenoAge, Klemera-Doubal biological age, and homeostatic dysregulation.
The existence of multiple validated approaches itself demonstrates that there is no one definitive biological-age number.
Scenario 14: Two valid algorithms return different ages
A person can be calculated as 48 under one model and 54 under another.
That does not necessarily mean one implementation is mathematically wrong; the models may represent different constructs.
PhenoAge is not Horvath DNAm age
Horvath-style clocks use DNA methylation measurements from CpG sites.
The calculator on this page uses routine clinical laboratory biomarkers and no DNA data.
PhenoAge is also not DNAm PhenoAge
DNAm PhenoAge is a later methylation-based biomarker trained partly using clinical PhenoAge-related information.
It requires DNA methylation data and is fundamentally different from entering nine blood-test values into the original clinical PhenoAge equation.
Epigenetic clocks have important individual-level limitations
A 2025 review argued that technical variation, tissue specificity, transient biological influences, reference-population effects, and absence of validated actionable thresholds limit their current use as personal clinical biomarkers.
The calculator should not imply that adding DNA automatically creates a definitive personal aging measurement.
A 2026 review describes clinical translation as still developing
Recent aging literature continues to discuss reliability, standardization, biological interpretation, and clinical utility as unresolved challenges.
The scientific field is advancing, but consumer language should not run ahead of the evidence.
Chronological age remains objectively different
Chronological age measures elapsed calendar time since birth.
Biological-age models summarize selected biological or risk-related measurements.
Use the Age Calculator for chronological age
The Age Calculator can determine exact calendar age from date of birth.
That objective calendar result should remain separate from the model-derived PhenoAge estimate.
BMI should remain a separate screening measurement
BMI does not enter the published PhenoAge equation.
Use the BMI Calculator when weight-for-height screening is the relevant question.
Body composition is also separate
The PhenoAge equation does not directly measure body-fat percentage or lean mass.
Use the Body Fat Calculator for circumference-based body-composition estimation.
Scenario 15: Same PhenoAge, different body composition
Two people can generate similar laboratory-model ages while having different muscle mass or body-fat percentage.
The aging model does not erase those differences.
Lab units are a major implementation risk
Several inputs are commonly reported differently in U.S. laboratories than they appear in the original equation.
Unit conversion should happen transparently and automatically.
Albumin conversion
Multiply g/dL by 10 to obtain g/L.
For example, 4.3 g/dL becomes 43 g/L.
Creatinine conversion
For conventional serum-creatinine conversion, mg/dL is converted to μmol/L before the PhenoAge coefficient is used.
The UI should retain the original entered value while displaying or documenting the converted internal value.
Glucose conversion
Glucose in mg/dL is converted to mmol/L before calculation.
Approximately 90 mg/dL corresponds to about 5.0 mmol/L.
Unit conversion should never be left implicit
A wrong unit can create an enormous but mathematically valid-looking error.
The result panel should state that U.S. conventional inputs were converted internally.
Input validation should use plausible laboratory ranges cautiously
Clearly impossible or unit-mismatched values should trigger validation.
But clinically unusual values should not simply be rejected because genuine laboratory abnormalities exist.
Scenario 16: Creatinine entered as 90 mg/dL instead of μmol/L
The number may reflect a unit misunderstanding rather than genuine physiology.
The application should detect likely unit mistakes before generating an extreme age result.
Missing biomarkers should not be replaced with population averages silently
Doing so creates a different algorithm from published PhenoAge.
Require all nine laboratory inputs for the canonical calculation.
Measurement timing matters
The biomarkers should ideally come from the same clinically coherent panel.
Combining a CRP from an infection six months ago with a current CBC and chemistry panel produces a synthetic profile that never existed biologically.
Repeated scores require comparable conditions
Tracking is more interpretable when laboratories, assay methods, health status, and timing are reasonably comparable.
Even then, a small change may represent ordinary analytical or biological variation.
Scenario 17: PhenoAge falls by two years after one month
That could reflect real biomarker change, recovery from illness, measurement variation, or several factors simultaneously.
The calculator cannot prove two years of aging were reversed in one month.
Avoid red-green “younger is good, older is bad” oversimplification
The score is multidimensional and statistical.
A neutral comparison display is more appropriate than turning the result into a gamified medical verdict.
The strongest UI explains why the result changed
If users compare two panels, show which input values changed and by how much.
Do not claim which biomarker “caused aging” because the equation reflects association rather than causal proof.
The model should be reproducible
Publish the equation, required units, conversions, CRP logarithm, mortality transformation, and model name.
Transparency is especially important for YMYL health calculators using statistical models.
The strongest result should identify the model explicitly
Display “Levine Phenotypic Age (PhenoAge)” rather than only “Your biological age.”
Then display chronological age, PhenoAge, simple difference, and a short limitation directly beneath the result.
Frequently asked questions
What is biological age?
Biological age is a broad research concept intended to summarize biological or physiological aging. There is no single universally accepted biological-age measurement.
What biological age model does this calculator use?
It uses Levine Phenotypic Age, or PhenoAge, based on chronological age and nine routine blood biomarkers.
What is Levine PhenoAge?
It is a mortality-derived aging biomarker developed from NHANES data and expressed on an age-like scale.
What blood tests are used in PhenoAge?
Albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean corpuscular volume, red-cell distribution width, alkaline phosphatase, and white blood cell count.
Does PhenoAge use chronological age?
Yes. Chronological age is one of the ten inputs in the published model.
Is PhenoAge an epigenetic clock?
No. This version of PhenoAge uses ordinary clinical laboratory biomarkers and chronological age, not DNA methylation.
Is PhenoAge the same as DNAm PhenoAge?
No. DNAm PhenoAge is a DNA-methylation-based aging biomarker. This calculator implements the original blood-biomarker Phenotypic Age model.
Do I need a DNA test?
No. This calculator requires the nine specified blood biomarkers and chronological age.
Does a younger biological age mean I will live longer?
Not necessarily. PhenoAge is associated with mortality risk at a population level but cannot predict an individual lifespan.
Does an older PhenoAge mean I am dying faster?
No such conclusion can be made from one result. The output is a statistical mortality-risk age estimate, not a measured personal aging rate.
What does it mean if my PhenoAge is five years younger?
Your entered biomarker profile maps to an age-like mortality-risk estimate about five years below your chronological age under the model. It does not mean five years have literally been added to your life.
What does it mean if my PhenoAge is five years older?
Your biomarker profile maps to an older age-like mortality-risk estimate in the model. It does not mean exactly five years of life expectancy have been lost.
Can PhenoAge predict my life expectancy?
No. It was derived from mortality associations but does not predict an individual death date or remaining lifespan.
Can PhenoAge diagnose disease?
No. It is a composite statistical biomarker rather than a diagnostic test.
Why is CRP included?
CRP is an inflammation-related biomarker that was selected as one of the variables contributing to the original mortality-prediction model.
Why can CRP not be zero?
The equation uses the natural logarithm of CRP, and ln(0) is mathematically undefined.
Does the equation use natural log or log base 10?
It uses the natural logarithm for CRP.
Why is albumin converted from g/dL?
The published model coefficient is applied to albumin in g/L, so common U.S. g/dL values need conversion.
Why is creatinine converted?
The published model uses creatinine in μmol/L, while many U.S. laboratories report mg/dL.
Why is glucose converted?
The model uses glucose in mmol/L while U.S. laboratories commonly report mg/dL.
Can I enter lab tests from different dates?
That is not recommended because the combined model should represent a clinically coherent biomarker profile.
Can illness change my biological-age result?
Yes. Acute illness can alter CRP, white blood cell count, glucose, albumin, and other inputs and therefore change PhenoAge.
Can dehydration change my result?
Potentially. Hydration status can affect some laboratory concentrations and should be considered when comparing results.
Can medications change PhenoAge?
Yes indirectly, because medications can change individual laboratory biomarkers. Do not change medication merely to optimize the score.
Can diet change PhenoAge?
Diet can influence health and some biomarkers over time, but a calculator cannot determine that a specific dietary change will reduce biological age by a predictable number of years.
Can exercise lower biological age?
Exercise can influence multiple health outcomes and biomarkers, but this calculator cannot predict a fixed number of PhenoAge years that exercise will remove.
Can I reverse biological aging?
A lower repeat PhenoAge score can occur when biomarkers change, but one calculator result cannot prove literal reversal of biological aging.
How often should I calculate PhenoAge?
There is no established clinical schedule. Repeated calculations are most interpretable when laboratory testing is medically appropriate and measurement conditions are reasonably comparable.
Is a one-year change meaningful?
Not necessarily. Laboratory variation, transient physiology, model error, and timing can produce small changes that should not automatically be interpreted as true aging acceleration or reversal.
What is PhenoAge acceleration?
In research, PhenoAgeAccel generally refers to a regression residual representing PhenoAge relative to what is expected for chronological age. It is not simply identical to PhenoAge minus chronological age.
What does this calculator show instead of PhenoAgeAccel?
It can show the simpler difference between estimated PhenoAge and chronological age and should label that value exactly as a difference.
Is there a perfect biological-age test?
No. Current scientific literature recognizes multiple aging biomarkers and no single gold-standard measure.
Are DNA methylation clocks better?
They measure a different biological layer. Current research continues to examine their reliability, interpretation, and clinical utility, particularly for individual decision-making.
Why do biological-age tests give different answers?
Different models use different biomarkers, reference populations, statistical methods, and outcome targets, so differing age estimates are expected.
Is chronological age more accurate?
Chronological age answers a different question and is objectively determined from calendar time. Use the Age Calculator for exact chronological age.
Does BMI affect PhenoAge?
BMI is not one of the direct inputs in the published PhenoAge equation. Use the BMI Calculator for BMI screening.
Does body-fat percentage affect PhenoAge?
Body-fat percentage is not a direct input. Use the Body Fat Calculator for a separate body-composition estimate.
What if one of my lab values is abnormal?
Discuss the actual abnormal laboratory result with a qualified healthcare professional based on its clinical significance rather than relying on the combined PhenoAge score.
Can I use PhenoAge to decide which supplements to take?
No. The model does not establish whether any supplement is appropriate, effective, or safe for an individual.
Can I use the calculator to change medication?
No. Do not start, stop, or change prescribed treatment based on a biological-age calculator.
How accurate is the biological age calculator?
The published equation can be reproduced mathematically when the laboratory values and units are correct. The larger limitation is interpretation: PhenoAge is a population-derived aging biomarker rather than a direct or definitive measurement of individual biological aging.
Sources and review
- A New Aging Measure Captures Morbidity and Mortality Risk Across Diverse Subpopulations From NHANES IV — PLOS Medicine / PubMed Central. Accessed 2026-09-01.
- A Toolkit for Quantification of Biological Age From Blood Chemistry and Organ Function Test Data: BioAge — GeroScience / PubMed Central. Accessed 2026-09-01.
- Association of Blood Chemistry Quantifications of Biological Aging With Disability and Mortality in Older Adults — Journals of Gerontology / PubMed Central. Accessed 2026-09-01.
- From Population Science to the Clinic? Limits of Epigenetic Clocks as Personal Biomarkers — Epigenomics / PubMed Central. Accessed 2026-09-01.
- Epigenetic Clocks: Advancing Biological Age Measures Towards Meaningful Clinical Use — eBioMedicine / PubMed Central. Accessed 2026-09-01.
- Epigenetic Ageing Clocks: Statistical Methods and Emerging Computational Challenges — Nature Reviews Genetics / PubMed. Accessed 2026-09-01.
Reviewed 2026-09-01 by Dr Akawak Ejigu, DBA.